TASK vs. CPRX
TASK (TaskUs, Inc.) and CPRX (Catalyst Pharmaceuticals, Inc.) are both stocks. TASK operates in Information Technology Services (Technology), while CPRX operates in Biotechnology (Healthcare). Over the past 5 years, TASK returned -19.26%/yr vs 39.71%/yr for CPRX. At a 0.27 correlation, their price movements are largely independent.
Performance
TASK vs. CPRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TASK achieves a -5.10% return, which is significantly lower than CPRX's 34.53% return.
TASK
- 1D
- -6.01%
- 1M
- -23.86%
- YTD
- -5.10%
- 6M
- -1.68%
- 1Y
- -33.20%
- 3Y*
- 0.20%
- 5Y*
- -19.26%
- 10Y*
- —
CPRX
- 1D
- 0.06%
- 1M
- 0.45%
- YTD
- 34.53%
- 6M
- 29.59%
- 1Y
- 41.95%
- 3Y*
- 33.66%
- 5Y*
- 39.71%
- 10Y*
- 44.45%
TASK vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
TASK TaskUs, Inc. | -5.10% | -30.40% | 29.61% | -22.66% | -68.68% | 95.86% |
CPRX Catalyst Pharmaceuticals, Inc. | 34.53% | 11.84% | 24.15% | -9.62% | 174.74% | 17.53% |
Correlation
The correlation between TASK and CPRX is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jun 11, 2021 | 0.27 |
Over the past year, the correlation between TASK and CPRX has dropped to 0.06 - well below their long-term average of 0.27, suggesting their price drivers have been diverging.
Fundamentals
TASK:
$436.61M
CPRX:
$3.98B
TASK:
$1.14
CPRX:
$1.74
TASK:
4.13
CPRX:
18.05
TASK:
0.10
CPRX:
0.32
TASK:
0.48
CPRX:
6.69
TASK:
1.59
CPRX:
3.93
TASK:
$905.76M
CPRX:
$596.96M
TASK:
$139.75M
CPRX:
$378.23M
TASK:
$214.94M
CPRX:
$313.50M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TASK vs. CPRX — Risk / Return Rank
TASK
CPRX
TASK vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for TaskUs, Inc. (TASK) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TASK | CPRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.74 | ||
| Sortino ratioReturn per unit of downside risk | -2.42 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.25 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | -0.72 | 3.03 | -3.75 |
| Martin ratioReturn relative to average drawdown | -1.31 | 7.92 | -9.23 |
Loading charts...
Drawdowns
TASK vs. CPRX - Drawdown Comparison
The maximum TASK drawdown since its inception was -90.21%, roughly equal to the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for TASK and CPRX.
Loading charts...
Drawdown Indicators
| TASK | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.21% | -94.25% | +4.04% |
Max Drawdown (1Y)Largest decline over 1 year | -46.46% | -13.91% | -32.55% |
Max Drawdown (3Y)Largest decline over 3 years | -48.52% | -27.29% | -21.23% |
Max Drawdown (5Y)Largest decline over 5 years | -90.21% | -45.37% | -44.84% |
Max Drawdown (10Y)Largest decline over 10 years | — | -64.87% | — |
Current DrawdownCurrent decline from peak | -86.60% | 0.00% | -86.60% |
Average DrawdownAverage peak-to-trough decline | -73.85% | -51.90% | -21.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.39% | 5.32% | +20.07% |
Volatility
TASK vs. CPRX - Volatility Comparison
TaskUs, Inc. (TASK) has a higher volatility of 15.03% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 0.46%. This indicates that TASK's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TASK | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.03% | 0.46% | +14.57% |
Volatility (6M)Calculated over the trailing 6-month period | 58.93% | 22.84% | +36.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 74.15% | 32.65% | +41.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 72.50% | 47.79% | +24.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 72.58% | 60.09% | +12.49% |
Dividends
TASK vs. CPRX - Dividend Comparison
TASK's dividend yield for the trailing twelve months is around 155.65%, while CPRX has not paid dividends to shareholders.
| Position | TTM |
|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% |
TASK TaskUs, Inc. | 155.65% |
Financials
TASK vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between TaskUs, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TASK and CPRX have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TASK has higher volatility (15.03%) compared to CPRX (0.46%). In terms of maximum drawdown, TASK dropped -90.21% vs CPRX's -94.25%.
CPRX currently has the higher Sharpe Ratio (1.29 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TASK and CPRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer